Skip to content

Study of urine biomarkers for hyperlipidemia

Study of urine biomarkers for hyperlipidemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016071
Enrollment
Unknown
Registered
2018-05-09
Start date
2018-05-31
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

Control group:no
hyperlipidemia group:no

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Selecting people aged between 20 and 70 years and in line with Western medicine diagnostic criteria for hyperlipidemia; 2. Primary hyperlipidemia; 3. Although taking lipid-regulating drugs, it has been discontinued for more than two weeks, and blood lipid levels still meet the diagnostic criteria.

Exclusion criteria

Exclusion criteria: Patients with chronic diseases including coronary heart disease, diabetes, malignant neoplasms, nephropathy, rheumatism, hyperuricemia, hypertension, hypothyroidism, hyperthyroidism, depression, etc.; exclude patients with AIDS and syphilis Patients with abnormal liver and kidney function excluded: Patients with abnormal CPK (phosphocreatine kinase), HbA1c, 2h postprandial blood glucose, alpha-fetoprotein, rheumatoid factor, ejection fraction, and abnormal blood pressure were excluded.

Design outcomes

Primary

MeasureTime frame
Biomarker detection of urine metabolites;

Countries

China

Contacts

Public ContactChunquan Yu

Tianjin University of Traditional Chinese Medicine

ycq-4@163.com+86 18622569428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026